IMR Press / RCM / Volume 24 / Issue 3 / DOI: 10.31083/j.rcm2403078
Open Access Original Research
Association between Fluid Balance and Treatment Outcome of Ibuprofen for Patent Ductus Arteriosus in Preterm Infants
Chang Liu1,2,3,4Yuan Shi1,2,3,4,*
Show Less
1 Department of Neonatology, Children’s Hospital of Chongqing Medical University, 400014 Chongqing, China
2 National Clinical Research Center for Child Health and Disorders, 400014 Chongqing, China
3 Ministry of Education Key Laboratory of Child Development and Disorders, 400014 Chongqing, China
4 Chongqing Key Laboratory of Pediatrics, 400014 Chongqing, China
*Correspondence: shiyuan@hospital.cqmu.edu.cn (Yuan Shi)
Rev. Cardiovasc. Med. 2023, 24(3), 78; https://doi.org/10.31083/j.rcm2403078
Submitted: 7 September 2022 | Revised: 15 November 2022 | Accepted: 28 November 2022 | Published: 3 March 2023
Copyright: © 2023 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract

Background: Excessive fluid intake is a predictor of the development of patent ductus arteriosus (PDA) in preterm infants. Previous studies have examined the relationship between fluid intake and outcomes following ibuprofen for PDA. However, there is a lack of data to determine whether fluid balance has an effect on ibuprofen treatment for PDA. Therefore, this study sought to determine the relationship between fluid balance and outcomes following treatment with ibuprofen for PDA. Methods: We conducted a retrospective study of 110 infants admitted to the Children’s Hospital of Chongqing Medical University between January 2017 and April 2022, who were treated with ibuprofen for hemodynamically significant PDA (hsPDA). We calculated the average fluid balance before and during the two courses of ibuprofen treatment and whether they were significantly associated with outcomes in hsPDA patients. Results: In the first course of ibuprofen treatment (FIT), responders had lower fluid balance before FIT compared to non-responders [median 31.82 (18.01, 39.66) vs 34.68 (25.31, 43.56) mL/kg/day; p = 0.049], while the fluid balance during FIT [median 40.61 (33.18, 63.06) vs 42.65 (30.02, 57.96) mL/kg/day; p = 0.703] did not differ between responders and non-responders. Fluid balance before the second course of ibuprofen treatment (SIT) (mean 41.58 ± 14.26 vs 35.74 ± 10.99 mL/kg/day; p = 0.322) and during SIT (mean 39.21 ± 12.65 vs 37.00 ± 21.38 mL/kg/day; p = 0.813) was not found to have a significant association with SIT outcome. Multivariate logistic regression analysis showed fluid balance before FIT was a predictor for FIT success [Odds ratio (OR): 0.967; 95% confidence interval (CI): 0.935–0.999; p = 0.042]. Fluid balance within the first week of life had a greater association with the FIT outcome (OR: 0.967, 95% CI: 0.939–0.996, p = 0.027). Gestational diabetes mellitus and higher Apgar scores decreased the possibility of PDA closure after FIT. Conclusions: Lower fluid balance before FIT, especially within the first week of life appeared to be a predictor for closure of hsPDA after FIT in preterm infants.

Keywords
patent ductus arteriosus
fluid balance
ibuprofen
preterm infants
Funding
2022YFC2704803/National Key Research and Development Program of China
Figures
Fig. 1.
Share
Back to top